• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    North America Veterinary Care Market

    ID: MRFR/HC/16219-HCR
    128 Pages
    Rahul Gotadki
    September 2025

    North America Veterinary Care Market Research Report Information By Animal Type (Dogs, Cats, Cattle, Pigs, Horses, and Poultry), By Treatment Type (No Medicalization, Basic Medicalization, and Veterinary Care)–and North America Market Forecast Till 2034

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    North America Veterinary Care Market Research Report—Forecast till 2034 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    North America Veterinary Care Market Summary

    The North America Veterinary Care market is projected to grow from 12.0 USD Billion in 2024 to 24.7 USD Billion by 2035.

    Key Market Trends & Highlights

    North America Veterinary Care Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 6.8 percent from 2025 to 2035.
    • By 2035, the North America Veterinary Care market is anticipated to reach a valuation of 24.7 USD Billion.
    • In 2024, the market is valued at 12.0 USD Billion, indicating a robust growth trajectory.
    • Growing adoption of advanced veterinary technologies due to increasing pet ownership is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.0 (USD Billion)
    2035 Market Size 24.7 (USD Billion)
    CAGR (2025-2035) 6.8%

    Major Players

    Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), Heska Corporation (US)

    North America Veterinary Care Market Trends

    Growing adoption of telemedicine in veterinary care is driving the market growth.

    The North American Veterinary Care market CAGR is expanding due to the adoption of telemedicine in veterinary care. It allows pet owners to connect with veterinarians remotely, seeking advice on non-emergency issues, discussing symptoms, and receiving guidance on basic healthcare. This trend has gained traction, especially with the advancements in digital communication technologies and the increased acceptance of virtual interactions. Telemedicine offers convenience for pet owners and helps address concerns promptly, reducing the need for physical visits unless absolutely necessary.

    This trend has become even more prominent after the COVID-19 pandemic, where remote services gained prominence to ensure safety and adhere to social distancing measures.

    Furthermore, the growth of the Veterinary Care market is influenced by a growing emphasis on preventive healthcare in North America. Pet owners increasingly recognize the importance of preventive measures to ensure their animals' well-being and avoid costly treatments for advanced illnesses. This shift in mindset has led to a raised demand for wellness exams, vaccinations, and preventive treatments. Veterinary clinics are responding by offering comprehensive preventive care packages, including regular check-ups, vaccinations, dental care, and nutritional counseling.

    This proactive approach benefits the health of pets and contributes to the long-term sustainability of the veterinary care market by reducing the burden of treating advanced diseases. Thus driving the Veterinary Care market revenue.

    Market Segment Insights

    Veterinary Care Animal Type Insights

    The North America Veterinary Care market segmentation, based on animal type, includes Dogs, Cats, Cattle, Pigs, Horses, and Poultry. The dogs segment dominated the market. With a focus on canine health, veterinary care services cater to the diverse needs of dog owners. This specialized segment addresses preventive care, medical treatments, and overall dog well-being, reflecting the region's commitment to providing comprehensive and specialized veterinary services for this popular pet species.

    Veterinary Care Treatment Type Insights

    The North America Veterinary Care market segmentation, based on treatment type, includes No Medicalization, Basic Medicalization, and Veterinary Care. The no medicalization category generated the most income. It signifies approaches in veterinary care that do not involve traditional medical interventions. It may include holistic or alternative therapies, preventive measures, or animal lifestyle adjustments, emphasizing non-medicalized strategies to maintain or enhance their well-being. This segment reflects a growing awareness and acceptance of non-conventional methods in veterinary care within the North American market.

    Figure 1: North America Veterinary Care Market, by Medicalization Type, 2022 & 2032 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Veterinary Care Country Insights

    The rapid expansion of the advancements in diagnostics has resulted in a boom in demand for Veterinary Care in North America in recent years. In the United States, the largest market in the region, the rising pet ownership and increasing awareness about animal health drive the demand for veterinary services. Advanced medical technologies, diagnostic tools, and therapeutic options contribute to the market's expansion. Canada exhibits a similar trend, with a growing emphasis on preventive care and pet wellness. Both countries witness a surge in pet insurance adoption, fostering comprehensive healthcare.

    While evolving, Mexico experiences a rising pet population and a gradual shift towards specialized veterinary services. The North American veterinary care market reflects a dynamic landscape shaped by evolving pet care preferences and advancing medical capabilities.

    Figure 2: NORTH AMERICA Veterinary Care MARKET SHARE BY REGION 2022 (USD Billion)

    Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

    Get more detailed insights about North America Veterinary Care Market Research Report—Forecast till 2034

    Key Players and Competitive Insights

    Leading market players are investing majorly in research and development to spread their product lines, which will help the Veterinary Care market grow even more. The participants also undertake various strategic activities to spread their footprint with new market developments, including product launches, contractual agreements, mergers and acquisitions, major investments, and collaboration with other organizations. The Veterinary Care industry must offer cost-effective items to spread and survive in a competitive and rising market climate.

    Major players in the Veterinary Care market are attempting to raise market demand by investing in research and development operations includes Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), Heska Corporation. (US).

    Key Companies in the North America Veterinary Care Market market include

    Industry Developments

    • Q2 2024: Zoetis Announces FDA Approval of Librela® (bedinvetmab) for the Control of Osteoarthritis Pain in Dogs in the United States Zoetis received FDA approval for Librela®, a monoclonal antibody therapy for the control of osteoarthritis pain in dogs, marking a significant regulatory milestone in the North American veterinary care market.
    • Q2 2024: Elanco Animal Health Announces U.S. Launch of Varenzin™-CA1, the First FDA-Approved Treatment for Nonregenerative Anemia in Cats with Chronic Kidney Disease Elanco launched Varenzin™-CA1 in the U.S., the first FDA-approved treatment for nonregenerative anemia in cats with chronic kidney disease, expanding its feline therapeutics portfolio.
    • Q2 2024: IDEXX Laboratories Launches Next-Generation Catalyst® One Chemistry Analyzer for Veterinary Practices IDEXX Laboratories introduced the next-generation Catalyst® One Chemistry Analyzer, offering enhanced diagnostic capabilities for veterinary clinics across North America.
    • Q3 2024: Mars Veterinary Health Opens New State-of-the-Art Veterinary Specialty and Emergency Hospital in Dallas, Texas Mars Veterinary Health opened a new specialty and emergency hospital in Dallas, Texas, expanding its network of advanced veterinary care facilities in North America.
    • Q3 2024: Zoetis Completes Acquisition of PetMedix to Expand Monoclonal Antibody Platform for Companion Animals Zoetis completed the acquisition of PetMedix, a UK-based biotech specializing in monoclonal antibody therapeutics for pets, strengthening its innovation pipeline in the North American market.
    • Q4 2024: Elanco Animal Health Appoints José Carlos González as President, North America Elanco Animal Health announced the appointment of José Carlos González as President, North America, to lead the company’s regional operations and growth strategy.
    • Q4 2024: VCA Animal Hospitals Announces Partnership with PetDesk to Enhance Client Communication and Appointment Management VCA Animal Hospitals partnered with PetDesk to implement advanced client communication and appointment management solutions across its North American clinics.
    • Q1 2025: Covetrus Launches New Veterinary Practice Management Software Platform, Covetrus Pulse™ Covetrus launched Covetrus Pulse™, a new cloud-based practice management software platform designed to streamline operations for veterinary practices in North America.
    • Q1 2025: Banfield Pet Hospital Opens 50th New Clinic in North America Since 2023 Banfield Pet Hospital celebrated the opening of its 50th new clinic in North America since 2023, reflecting ongoing expansion in veterinary care access.
    • Q2 2025: Zoetis Receives FDA Approval for Solensia® (frunevetmab) for the Control of Osteoarthritis Pain in Cats in the United States Zoetis received FDA approval for Solensia®, a monoclonal antibody therapy for the control of osteoarthritis pain in cats, further expanding its U.S. companion animal therapeutics portfolio.
    • Q2 2025: Elanco Animal Health Announces $200 Million Investment to Expand Manufacturing Facility in Indiana Elanco Animal Health announced a $200 million investment to expand its manufacturing facility in Indiana, aimed at increasing production capacity for veterinary medicines.
    • Q2 2025: IDEXX Laboratories Acquires ezyVet, a Leading Cloud-Based Veterinary Practice Management Software Provider IDEXX Laboratories acquired ezyVet, a cloud-based veterinary practice management software provider, to enhance its digital solutions offering for North American veterinary practices.

    Market Segmentation

    Veterinary Care Regional Outlook

    • US
    • Canada
    • Mexico
    • Rest of North America

    Veterinary Care Animal Type Outlook

    • Dogs
    • Cats
    • Cattle
    • Pigs
    • Horses
    • Poultry

    Veterinary Care Medicalization Type Outlook

    • No Medicalization
    • Basic Medicalization
    • Veterinary Care

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024   11.97 (USD Billion)
    Market Size 2025   12.79 (USD Billion)
    Market Size 2034   23.12 (USD Billion)
    Compound Annual Growth Rate (CAGR)    6.80 % (2025 - 2034)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2034
    Historical Data 2020 - 2024
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Animal Type, Medicalization Type, and Region
    Region Covered North America
    Countries Covered The US, Canada, Mexico, and the Rest of North America
    Key Companies Profiled Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation. (US)
    Key Market Opportunities ·       Growing awareness of the role of preventive healthcare for pets
    Key Market Dynamics ·       Growing trend of considering pets as family members ·       Increasing adoption of pet insurance

    FAQs

    How much is the Veterinary Care market?

    The North America Veterinary Care market was valued at USD 10.5 Billion in 2022.

    What is the growth rate of the Veterinary Care market?

    The market is projected to grow at a CAGR of 6.80% during the forecast period, 2025-2034.

    Who are the key players in the Veterinary Care market?

    The key players in the market are Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), Virbac SA (France), IDEXX Laboratories, Inc. (US), Neogen Corporation (US), and Heska Corporation. (US).

    Which animal type led the Veterinary Care market?

    The dogs category dominated the market in 2022.

    Which medicalization type had the largest market share in the Veterinary Care market?

    The no-medicalization category had the largest share of the market.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials